chartexchange

AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
30.28USD+1.423%(+0.42)1,618,683
Pre-marketNov 13, 2026 9:13:30 AM EST
29.72USD-0.469%(-0.14)
After-hoursNov 13, 2026 4:35:30 PM EST
30.29USD+0.017%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$29.86
Beta
1.03
52-Week High
$41.14 2026-08-21
52-Week Low
$10.83 2026-01-05
SMA 50
$29.72
SMA 200
$20.72
Avg. Vol 10D
1.52M
Avg. Vol 30D
1.38M
Avg. Vol 90D
2.05M
Relative Vol
1.17
128.56M
108.88M
12,823,384
0.3500%
1,600,000
AMLX Profile

Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.

AMLX Performance
PeriodPriceDateChangeBeta
1W29.502026-11-06+2.71%1.792
1M26.852026-10-13+12.85%1.496
3M22.482026-08-13+34.79%0.527
6M14.582026-05-13+107.82%0.890
1Y12.422025-11-13+143.96%1.034
2Y5.682024-11-13+433.45%—
5Y18.072022-01-07+67.68%0.988
AMLX Stock Summary

Amylyx Pharmaceuticals, Inc. Common Stock (NASDAQ:AMLX) stock price today is $30.30, and today's volume is 1,618,683. AMLX is up 1.474% today. The 30 day average volume is 1.38M. AMLX market cap is $3.90B with 128.56M shares outstanding.